Literature DB >> 19128853

Study of awareness among pregnant women of the effects of drugs on the fetus and mother in Iran.

Simin O Mashayekhi1, Maryam Dilmaghanizadeh, Zahra Fardiazar, Roghayeh Bamdad-Moghadam, Fahimeh Ghandforoush-Sattari.   

Abstract

OBJECTIVE: The aim of the study was to examine the awareness of Iranian pregnant women about the effects of drugs in pregnancy.
METHODS: Awareness of 400 women in postnatal and prenatal wards was assessed using self-completion questionnaire, which included demographic information, medication use, and the level of information regarding the safety of drugs during pregnancy and the most susceptible periods in pregnancy.
RESULTS: Out of 400 participants from prenatal and postnatal wards of two hospitals, 19.0% used medications other than vitamins and minerals supplements during pregnancy, and 7% believed in the safety of medications for mother and/or fetus during pregnancy. The first and second trimesters were believed to be the most and the least susceptible periods of pregnancy, respectively. Most information on drugs safety in pregnancy was obtained from physicians and health centers.
CONCLUSIONS: Present study indicates weaknesses in the awareness of this population and weak role of pharmacists in informing this vulnerable population. This study shows the requirement of training of this group of people in order to enhance the health of our community.

Entities:  

Mesh:

Year:  2009        PMID: 19128853     DOI: 10.1016/j.healthpol.2008.11.011

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  2 in total

1.  Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies.

Authors:  Molly M Lynch; Linda B Squiers; Katherine M Kosa; Suzanne Dolina; Jennifer Gard Read; Cheryl S Broussard; Meghan T Frey; Kara N Polen; Jennifer N Lind; Suzanne M Gilboa; Janis Biermann
Journal:  Matern Child Health J       Date:  2018-01

2.  Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment effectiveness and patient preferences.

Authors:  Aireen Wingert; Jennifer Pillay; Meghan Sebastianski; Michelle Gates; Robin Featherstone; Kassi Shave; Ben Vandermeer; Lisa Hartling
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.